{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:31:57Z","timestamp":1768901517131,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IRSC-CIHR","award":["119195"],"award-info":[{"award-number":["119195"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-018-0978-0","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:40:01Z","timestamp":1546944001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians\u2019 current practices"],"prefix":"10.1186","volume":"14","author":[{"name":"In collaboration with the Canadian Inherited Metabolic Diseases Research Network (CIMDRN)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Yuskiv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth K.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alette","family":"Giezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Ratko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranesh","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Paul","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Pender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376:1417\u201327.","journal-title":"Lancet"},{"issue":"2","key":"978_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/gim.2013.179","volume":"16","author":"RH Singh","year":"2014","unstructured":"Singh RH, Rohr F, Frazier D, et al. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med. 2014;16(2):121\u201331.","journal-title":"Genet Med"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16:188\u2013200.","journal-title":"Genet Med."},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ Wegberg van","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gi\u017cewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12:162.","journal-title":"Orphanet J Rare Dis"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","volume":"92","author":"SE Waisbren","year":"2007","unstructured":"Waisbren SE, Noel K, Fahrbach K, et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab. 2007;92:63\u201370.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 2","key":"978_CR6","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1007\/PL00014392","volume":"159","author":"I Smith","year":"2000","unstructured":"Smith I, Knowles J. Behaviour in early treated phenylketonuria: a systematic review J. Eur J Pediatr. 2000;159(Suppl 2):S89.","journal-title":"Eur J Pediatr"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","volume":"101","author":"GM Enns","year":"2010","unstructured":"Enns GM, Koch R, Brumm V, Blakely E, Suter R, Jurecki E. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence. Mol Genet Metab. 2010;101:99\u2013109.","journal-title":"Mol Genet Metab"},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1067\/mpd.2002.123663","volume":"140","author":"MA Landolt","year":"2002","unstructured":"Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr. 2002;140:516\u201321.","journal-title":"J Pediatr"},{"issue":"4","key":"978_CR9","doi-asserted-by":"publisher","first-page":"i","DOI":"10.2307\/1166208","volume":"62","author":"A Diamond","year":"1997","unstructured":"Diamond A. Monographs of the Society for Research in Child Development: Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev. 1997;62(4):i\u2013v 1-208.","journal-title":"Monogr Soc Res Child Dev"},{"issue":"3","key":"978_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2017.01.001","volume":"120","author":"ER Jurecki","year":"2017","unstructured":"Jurecki ER, Cederbaum S, Kopesky J, Perry K, Rohr F, Sanchez-Valle A, Viau KS, Sheinin MY, Cohen-Pfeffer JL. Adherence to clinic recommendations among patients with phenylketonuria in the United States. Mol Genet Metab. 2017;120(3):190\u20137.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"978_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","volume":"33","author":"A MacDonald","year":"2010","unstructured":"MacDonald A, Gokmen-Ozel H, van Rijn M, Burgard P. The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis. 2010;33(6):665\u201370.","journal-title":"J Inherit Metab Dis"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1203\/00006450-200104000-00015","volume":"49","author":"J Weglage","year":"2001","unstructured":"Weglage J, Pietsch M, Feldmann R, et al. Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res. 2001;49:532\u20136.","journal-title":"Pediatr Res"},{"key":"978_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpeds.2004.04.029","volume":"145","author":"CS Camfield","year":"2004","unstructured":"Camfield CS, Joseph M, Hurley T, Campbell K, Sanderson S, Camfield PR. Optimal management of phenylketonuria: a centralized expert team is more successful than a decentralized model of care. J Pediatr. 2004;145:53\u20137.","journal-title":"J Pediatr"},{"issue":"9","key":"978_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","volume":"5","author":"FJ Spronsen van","year":"2017","unstructured":"van Spronsen FJ, van Wegberg AM, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gi\u017cewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, Trefz FK, van Rijn M, Walter JH, MacDonald A. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"978_CR15","unstructured":"European Society for Phenylketonuria and Allied Disorders: PKU: Closing the Gaps in Care. An ESPKU benchmark report on the management of phenylketonuria within EU healthcare economies. Available at: \n                    http:\/\/www.espku.org\/wp-content\/uploads\/2015\/06\/PKU_report_FINAL_v2_nomarks.pdf\n                    \n                  . Accessed 1 Feb 2018."},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1542\/peds.108.4.972","volume":"108","author":"National Institutes of Health Consensus Development Panel, National Institutes of Health Consensus Development Conference Statement","year":"2001","unstructured":"National Institutes of Health Consensus Development Panel, National Institutes of Health Consensus Development Conference Statement. Phenylketonuria (PKU): Screening and Management, October 16\u201318, 2000. Pediatrics. 2001;108:972\u201382.","journal-title":"Pediatrics"},{"key":"978_CR17","volume-title":"Adjuvant Treatment for Phenylketonuria (PKU)","author":"ML Lindegren","year":"2012","unstructured":"Lindegren ML, Krishnaswami S, Fonnesbeck C, et al. Adjuvant Treatment for Phenylketonuria (PKU). Rockville: Agency for Healthcare Research and Quality (US); 2012. (Comparative Effectiveness Reviews, No. 56.) Available at: \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK91350\/\n                    \n                  . Accessed 12 Mar 2018"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2753.2011.01807.x","volume":"19","author":"RH Singh","year":"2011","unstructured":"Singh RH, Rohr F, Splett PL. Bridging evidence and consensus methodology for inherited metabolic disorders: creating nutrition guidelines. J Eval Clin Pract. 2011;19:584\u201390.","journal-title":"J Eval Clin Pract"},{"key":"978_CR19","volume-title":"Mail and internet surveys. The tailored design method","author":"DA Dillman","year":"2007","unstructured":"Dillman DA. Mail and internet surveys. The tailored design method. 2nd ed. New York: Wiley, Inc; 2007.","edition":"2"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0163278707307899","volume":"30","author":"JB Geest van","year":"2007","unstructured":"van Geest JB, Johnson TP, Welc VL. Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof. 2007;30:303\u201321.","journal-title":"Eval Health Prof"},{"key":"978_CR21","unstructured":"SERC-GMDI PKU Nutritional Guidelines. Available at: \n                    https:\/\/southeastgenetics.org\/ngp\/guidelines.php\/90\/PKU%20Nutrition%20Guidelines\/Version%201.12\n                    \n                  . Accessed 28 Mar 2018."},{"key":"978_CR22","doi-asserted-by":"crossref","unstructured":"Bernstein LE, Rohr F, Helm JR (eds). Nutrition Management of Inherited Metabolic Diseases, Springer International Publishing Switzerland; 2015.","DOI":"10.1007\/978-3-319-14621-8"},{"key":"978_CR23","unstructured":"G\u00fcttler F. Acta p\u00e6diatrica Scandinavica. Supplement: Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Almquist Wiksell. 1980;280:1."},{"key":"978_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/8904_2014_347","volume":"21","author":"MF Lamoureux","year":"2015","unstructured":"Lamoureux MF, Tingley K, Kronick JB, Potter BK, Chan AK, Coyle D, Dodds L, Dyack S, Feigenbaum A, Geraghty M, Gillis J, Rockman-Greenberg C, Khan A, Little J, MacKenzie J, Maranda B, Mhanni A, Mitchell JJ, Mitchell G, Laberge AM, Potter M, Prasad C, Siriwardena K, Speechley KN, Stockler S, Trakadis Y, Turner L, Van Karnebeek C, Wilson K, Chakraborty P. Canadian Inherited Metabolic Diseases Research Network. Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada. JIMD Rep. 2015;21:15\u201322.","journal-title":"JIMD Rep"},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10545-008-0937-3","volume":"32","author":"F Spronsen van","year":"2009","unstructured":"van Spronsen F, van Rijn M, Dorgelo B, Hoeksma M, Bosch AM, Mulder MF, de Klerk JBC, de Koning T, Estela Rubio-Gozalbo M, de Vries M, Verkerk PH. Phenylalanine tolerance can already reliably be assessed at the age of 2 years in patients with PKU. J Inherit Metab Dis. 2009;32:27.","journal-title":"J Inherit Metab Dis"},{"issue":"0","key":"978_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymgme.2012.07.008","volume":"107","author":"ME Quirk","year":"2012","unstructured":"Quirk ME, Dobrowolski SF, Nelson BE, Coffee B, Singh RH. Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria. Mol Genet Metab. 2012;107(0):31\u20136.","journal-title":"Mol Genet Metab"},{"issue":"Suppl","key":"978_CR27","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","volume":"104","author":"N Blau","year":"2011","unstructured":"Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab. 2011;104(Suppl):S2\u20139.","journal-title":"Mol Genet Metab"},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jpeds.2007.02.017","volume":"150","author":"B Fiege","year":"2007","unstructured":"Fiege B, Blau N. Assessment of tetrahydrobiopterin (BH4)-responsiveness in phenylketonuria. J Pediatr. 2007;150:627\u201330.","journal-title":"J Pediatr"},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","volume":"30","author":"BK Burton","year":"2007","unstructured":"Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA, Abadie V, Harding CO, Cederbaum S, Dobbelaere D, Smith A, Dorenbaum A. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicenter, open-label, screening study. J Inherit Metab Dis. 2007;30:700\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"978_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ymgme.2013.01.007","volume":"108","author":"C Hartnett","year":"2013","unstructured":"Hartnett C, Salvarinova-Zivkovic R, Yap-Todos E, Cheng B, Giezen A, Horvath G, Lillquist Y, Vallance H, Stockler-Ipsiroglu S. Long-term outcomes of blood phenylalanine concentrations in children with classical phenylketonuria. Mol Genet Metab. 2013;108(4):255\u20138.","journal-title":"Mol Genet Metab"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-277X.2008.00891.x","volume":"21","author":"A MacDonald","year":"2008","unstructured":"MacDonald A, Davies P, Daly A, Hopkins V, Hall SK, Asplin D, et al. Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria? J Hum Nutr Diet. 2008;21:351\u20138.","journal-title":"J Hum Nutr Diet"},{"key":"978_CR32","doi-asserted-by":"crossref","unstructured":"Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, et al. How practical are recommendations for dietary control in phenylketonuria? Lancet. 2002;360:55\u20138.","DOI":"10.1016\/S0140-6736(02)09334-0"},{"key":"978_CR33","doi-asserted-by":"crossref","unstructured":"Sharman R, Mulgrew K, Katsikitis M. Qualitative Analysis of Factors Affecting Adherence to the Phenylketonuria Diet in Adolescents. Clin Nurse Spec. 2013;27(4):205\u201310.","DOI":"10.1097\/NUR.0b013e31829555d5"},{"issue":"3","key":"978_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10545-011-9283-y","volume":"34","author":"FJ Spronsen van","year":"2011","unstructured":"van Spronsen FJ. Mild hyperphenylalaninemia: to treat or not to treat. J Inherit Metab Dis. 2011;34(3):651\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"978_CR35","first-page":"159","volume":"10","author":"R Surtees","year":"2000","unstructured":"Surtees R, Blau N. The neurochemistry of phenylketonuria. Eur J Pediatr. 2000;10:159 Suppl 2.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"978_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1586\/14737159.2014.923760","volume":"14","author":"N Blau","year":"2014","unstructured":"Blau N, Shen N, Carducci C. Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn. 2014;14(6):655\u201371.","journal-title":"Expert Rev Mol Diagn"},{"key":"978_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10545-010-9216-1","volume":"33","author":"FJ Spronsen van","year":"2010","unstructured":"van Spronsen FJ, De Groot MJ, Hoeksma M, Reijngoud DJ, Van Rijn M. Large neutral amino acids in the treatment of PKU: from theory to practice. J Inherit Metab Dis. 2010;33:671\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"978_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10545-007-0556-4","volume":"30","author":"R Matalon","year":"2007","unstructured":"Matalon R, Michals-Matalon K, Bhatia G, Burlina AB, Burlina AP, Braga C, Fiori L, Giovannini M, Grechanina E, Novikov P, Grady J, Tyring SK, Guttler F. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine. J Inherit Metab Dis. 2007;30(2):153\u20138.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0978-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T19:21:27Z","timestamp":1578424887000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0978-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The survey study protocol was submitted to Research Ethics Board of the University of British Columbia and received initial REB approval in August 8, 2015 (H15\u201301291).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Stockler received research funding for clinical trials related to PAH deficiency (PKU015, PKU 016, BioMarin). The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}